InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
4
Disclosed sells
2
T+90 hit rate
100%
T+90 mean return
+23.8%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Ryan Barbara, Director. Officer active across 5 companies, notably Indivior Pharmaceuticals, Inc.. Aggregated, 23 disclosures have been published. Split: 4 buys · 2 sells. Total volume traded: €39k. Activity tracked since 15 January 2022. The latest transaction was filed on 13 May 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Ryan Barbara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
6,518 shares0Common StockSEC:0001827169-26-000013:0
8 shares@ US$31.08519.8% of flowCommon StockSEC:0001827169-26-000010:0
Canonical exit: 11 Jun 2026 (T+90)
31 shares@ US$32.5680.2% of flowCommon StockSEC:0001827169-26-000008:0
Canonical exit: 7 Jun 2026 (T+90)
200 shares@ US$10.17250.7% of flowCommon StockSEC:0001193125-26-102581:0
400 shares@ US$10.85831.5% of flowCommon StockSEC:0001193125-26-091707:0
3,722 shares0Common StockSEC:0001827169-26-000006:0
775 shares@ US$35.3926100.0% of flowOrdinary SharesSEC:0001827169-26-000004:0
Canonical exit: 5 Apr 2026 (T+90)
1,601 shares@ US$11.096.2% of flowCommon StockSEC:0001193125-25-306678:0
1,281 shares@ US$13.866.6% of flowCommon StockSEC:0001193125-25-195090:0
2,476 shares@ US$7.177.2% of flowCommon StockSEC:0000950170-25-081608:0
2,019 shares@ US$8.798.5% of flowCommon StockSEC:0000950170-25-033523:0
24,229 shares@ US$0.738.3% of flowCommon StockSEC:0000950170-24-132525:0
21,649 shares@ US$0.828.0% of flowCommon StockSEC:0000950170-24-103750:0
17,841 shares@ US$0.998.1% of flowCommon StockSEC:0000950170-24-069215:0
18,685 shares@ US$0.958.2% of flowCommon StockSEC:0000950170-24-026422:0
17,068 shares@ US$1.048.1% of flowCommon StockSEC:0000950170-23-068322:0
12,158 shares@ US$1.468.1% of flowCommon StockSEC:0000950170-23-046774:0
10,086 shares@ US$1.768.2% of flowCommon StockSEC:0000899243-23-014414:0
8,493 shares@ US$2.098.3% of flowCommon StockSEC:0000899243-23-006913:0
6,801 shares@ US$2.618.5% of flowCommon StockSEC:0000899243-22-037650:0
13,550 shares@ US$2.6217.7% of flowCommon StockSEC:0000899243-22-031529:0
10,526 shares@ US$0.95100.0% of flowCommon StockSEC:0001493152-22-015911:0
Canonical exit: 30 Aug 2022 (T+90)
8,588 shares0Common StockSEC:0001493152-22-001529:0
23 of 23 declarations
About Ryan Barbara
Ryan Barbara is a director at MiNK Therapeutics, Inc., Indivior Pharmaceuticals, Inc., INVO Bioscience, Inc. and Indivior PLC. The file shows 23 filings in total, and across the sampled recent filings from 2022-01-18 to 2026-05-14, the buy amount is EUR 33912 and the sell amount is EUR 5445, with the modal transaction nature listed as Attribution.
